Skip to main content
Subscribe
Register
Sign in
Membership
Insights
Events
About
Subscribe
Register
Sign in
Valeant
Latest Articles
Daily Agenda: China Jitters Rattle Global Markets
Andrew Barber
Daily Agenda: Chinese GDP More Robust than Expected
Andrew Barber
Daily Agenda: Chinese Leaders Consider Loosening Capital Controls
Andrew Barber
Daily Agenda: Despite Rate Cut, Growth Expectations for China Weaken
Andrew Barber
Daily Agenda: European Equities Stage Modest Rally
Andrew Barber
Daily Agenda: Liquidity Fuels Continuing M&A Boom
Andrew Barber
Daily Agenda: Markets Remain Unsure of Fed Hike
Andrew Barber
Daily Agenda: The Week Ahead, November 2 – 7, 2015
Andrew Barber
Premium
Inside the Trade: What Bill Ackman Sees in Valeant and Allergan
Michael Peltz
Investing in the Health Care Revolution
Kaitlin Ugolik
Premium
Jeffrey Ubben’s ValueAct Continues to Surge Despite its Valeant Stake
Stephen Taub
Premium
Keeping Tabs on the Damage from a Cratering Valeant
Stephen Taub
Pharmaceutical Companies Gird for Drug-Price Reckoning
Kaitlin Ugolik
The Morning Brief: A Big Tuesday for Activist Targets
Stephen Taub
The Morning Brief: A Big Tuesday for Bill Ackman's Pershing Square
Stephen Taub
The Morning Brief: A Tough Time for CTAs
Stephen Taub
The Morning Brief: Ackman Concedes Valeant “Was a Huge Mistake”
Stephen Taub
The Morning Brief: Ackman on the Value in Valeant
Stephen Taub
More Articles